# First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma

> **NCT01371201** · PHASE2 · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 78 (actual)

## Conditions studied

- Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)

## Interventions

- **DRUG:** Sunitinib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01371201
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12-22
- **Primary completion:** 2013-10-01
- **Final completion:** 2021-04-20
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2022-08-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01371201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01371201, "First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01371201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*